Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
When both parents carry one copy of the same recessive gene variant, each pregnancy carries a 25% chance the child is affected, a 50% chance the child is an unaffected carrier, and a 25% chance the child inherits neither variant. Because that 25% risk resets with every pregnancy, families are typically offered carrier testing, genetic counseling, and options such as prenatal or preimplantation genetic testing, while an unaffected sibling has roughly a two-in-three chance of being a carrier. Several factors change how this risk is monitored and managed, including the specific condition, its severity, family history, and ancestry, so see below to understand the details that matter for your situation. Because symptoms of recessive conditions can be subtle, delayed, or noticeably different between siblings, getting clarity on what you or your child is actually experiencing is an important first step. A free, instant, online symptom check can help you organize your symptoms, see which conditions fit the pattern, and decide whether a primary care visit, specialist referral, or genetic counseling should come next.
Last reviewed for medical accuracy: 08/18/2026
Pseudo-vitamin D deficiency rickets genetic inheritance follows an autosomal recessive pattern. That means a child must inherit two altered copies of the CYP27B1 gene—one from each parent—to develop the condition. When both parents carry one altered gene, each pregnancy carries:
In this overview, we’ll explain how autosomal recessive transmission works, what it means for families facing pseudo-vitamin D deficiency rickets, and how that 25-percent sibling risk is managed.
Every person carries two copies of almost every gene—one inherited from mom, one from dad. Genes come in different versions called alleles. In autosomal recessive conditions:
If a child inherits:
Both parents must at least be carriers (R/r) for there to be a risk of an affected child.
When both parents are carriers (each R/r), each pregnancy is genetically independent, with these probabilities:
| Child’s Genotype | Outcome | Probability |
|---|---|---|
| R + R | Unaffected, not carrier | 25% |
| R + r or r + R | Unaffected, carrier | 50% |
| r + r | Affected | 25% |
Even if one child is already affected, each new pregnancy still carries the same 25% risk. That’s because each egg and each sperm carries one allele, and they combine independently every time.
Pseudo-vitamin D deficiency rickets (PDDR) is caused by mutations in CYP27B1, the gene encoding the enzyme 1-alpha hydroxylase. This enzyme converts inactive vitamin D into its active form (1,25-dihydroxyvitamin D), which is essential for:
Without sufficient active vitamin D, children develop rickets—soft, weak bones that can lead to bowed legs, delayed growth, and muscle weakness.
Key features:
Families with a known CYP27B1 mutation have several options to manage the 25% risk:
These approaches help families make informed decisions without undue anxiety, balancing realistic expectations with reproductive freedom.
A genetic counselor is a trained professional who helps families understand:
Counseling sessions typically cover:
Accurate diagnosis requires combining clinical findings with laboratory and genetic testing:
Laboratory profile
Genetic testing
Early testing is crucial. Delayed diagnosis can lead to prolonged bone problems, whereas prompt treatment can normalize growth and bone health.
Fortunately, pseudo-vitamin D deficiency rickets is treatable once diagnosed:
With proper treatment:
Discovering a genetic condition can be stressful. Here are strategies to keep anxiety in check:
Always speak to a healthcare professional if you notice:
Any of these could indicate a serious issue that needs prompt medical attention.
For personalized guidance about symptoms or concerns, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Above all, never hesitate to speak to a doctor about anything life-threatening or serious—timely care can make all the difference.
(References)
* Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am. 2003 Sep;32(3):877-89, vi-vii. doi: 10.1016/s0889-8553(03)00050-5. PMID: 14562579.
* Chapman DD. Cancer genetics. Semin Oncol Nurs. 2007 Feb;23(1):2-9. doi: 10.1016/j.soncn.2006.11.002. PMID: 17303511.
* Peshkin BN. Breast cancer risk assessment and genetic testing: complexities, conundrums, and community. Breast Dis. 2006-2007;27:1-3. doi: 10.3233/bd-2007-27101. PMID: 17917137.
* Alonso-Cerezo MC, Pérez-Pérez P. [Li-Fraumeni syndrome]. Med Clin (Barc). 2011 Oct 8;137(9):425-6. doi: 10.1016/j.medcli.2010.11.011. Epub 2011 Feb 22. PMID: 21345471.
* Hindi Muñiz N, Lamarca Lete A, Feliú Batlle J. [Hereditary colorectal cancer]. Med Clin (Barc). 2012 Mar 3;138(5):220-3. doi: 10.1016/j.medcli.2011.09.019. Epub 2011 Nov 16. PMID: 22093404.
* Jayadev S, Bird TD. Hereditary ataxias: overview. Genet Med. 2013 Sep;15(9):673-83. doi: 10.1038/gim.2013.28. Epub 2013 Mar 28. PMID: 23538602.
* Kruszka P, Martinez AF, Muenke M. Molecular testing in holoprosencephaly. Am J Med Genet C Semin Med Genet. 2018 Jun;178(2):187-193. doi: 10.1002/ajmg.c.31617. Epub 2018 May 17. PMID: 29771000; PMCID: PMC6125165.
* Walker M, Sobel M. Diagnosing ovarian cancer. CMAJ. 2018 Oct 22;190(42):E1259. doi: 10.1503/cmaj.180499. PMID: 30348741; PMCID: PMC6199160.
* Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, CGC, Karlan BY, Khan S, Klein C, Kohlmann W, CGC, Kurian AW, Laronga C, Litton JK, Mak JS, LCGC, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G, CGC, Senter-Jamieson L, CGC, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001. Epub 2021 Jan 6. PMID: 33406487.
* Myles A. Genes, discovery and life decisions. CMAJ. 2024 Feb 19;196(6):E193-E194. doi: 10.1503/cmaj.230750. Epub 2024 Feb 19. PMID: 38378220; PMCID: PMC10890227.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.